Stephen R. Lee

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Immunicon Corp. develops, manufactures, markets and sells proprietary cell-based diagnostic and research products and services. It provides services to pharmaceutical and biotechnology companies to develop new therapeutic agents, which focuses on cancer disease management. Immunicon's products and technology platforms have application in cancer research and in other fields of medicine, such as cardiovascular and infectious disease. The company was founded in 1983 and is headquartered in Huntingdon Valley, PA.